Klaus W. Wagner's most recent trade in Boundless Bio Inc. was a trade of 102,564 Stock Option done . Disclosure was reported to the exchange on Aug. 19, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Boundless Bio Inc | Klaus W. Wagner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 102,564 | 102,564 | - | - | Stock Option | |
| Boundless Bio Inc | Klaus W. Wagner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 102,564 | 0 | - | - | Stock Option | |
| Boundless Bio Inc | Klaus W. Wagner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 94,871 | 94,871 | - | - | Stock Option | |
| Boundless Bio Inc | Klaus W. Wagner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 94,871 | 0 | - | - | Stock Option | |
| Boundless Bio Inc | Klaus W. Wagner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 68,080 | 68,080 | - | - | Stock Option | |
| Boundless Bio Inc | Klaus W. Wagner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 68,080 | 0 | - | - | Stock Option | |
| Boundless Bio Inc | Klaus W. Wagner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 41,745 | 41,745 | - | - | Stock Option | |
| Boundless Bio Inc | Klaus W. Wagner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 41,745 | 0 | - | - | Stock Option | |
| Boundless Bio Inc | Klaus W. Wagner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 9,635 | 9,635 | - | - | Stock Option | |
| Boundless Bio Inc | Klaus W. Wagner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 9,635 | 0 | - | - | Stock Option | |
| Boundless Bio Inc | Klaus W. Wagner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 41,745 | 41,745 | - | - | Stock Option | |
| Inhibrx Inc | Klaus W. Wagner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.32 per share. | 16 Feb 2021 | 156,474 | 234,709 | - | 24.3 | 3,805,448 | Common Stock |
| Inhibrx Inc | Klaus W. Wagner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.29 per share. | 16 Feb 2021 | 19,559 | 215,150 | - | 25.3 | 494,647 | Common Stock |